Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04079296
Title A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Astellas Pharma Global Development, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Memorial Healthcare System-West Pembroke Pines Florida 33028 United States Details
NYU Langone Health New York New York 10016 United States Details
Site JP81005 Nagoya Aichi Japan Details
Site JP81016 Matsuyama Ehime Japan Details
Site JP81009 Yoshida-gun Fukui Japan Details
Site JP81004 Maebashi Gunma Japan Details
Site JP81007 Kobe Hyogo Japan Details
Site JP81013 Isehara Kanagawa Japan Details
Site JP81017 Sendai Miyagi Japan Details
Site JP81001 Shinagawa Tokyo Japan Details
Site JP81002 Fukuoka Japan Details
Site JP81010 Gifu Japan Details
Site JP81008 Okayama Japan Details
Site JP81011 Osaka Japan Details
Site JP81012 Osaka Japan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field